Recent Insights of Matrix Metalloproteinase Inhibitors in Therapeutic Applications
- Authors: Ravichandran Rathna, Bethu Madhumitha, Ravichandran Viveka, Ekambaram Nakkeeran4
-
View Affiliations Hide AffiliationsAffiliations: 4 Research Laboratory, Department of Biotechnology, Sri Venkateswara College of Engineering (Autonomous), Sriperumbudur Tk 602 117, Tamil Nadu, India
- Source: Enzyme Inhibition - Environmental and Biomedical Applications , pp 73-96
- Publication Date: August 2020
- Language: English
Recent Insights of Matrix Metalloproteinase Inhibitors in Therapeutic Applications, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789811460821/chapter-6-1.gif
Matrix metalloproteinases are proteolytic zinc-dependent enzymes that play a pivotal function in cell migration, proliferation, differentiation, programmed cell death, and other physiological processes. Recent studies demonstrated that the imbalance activation and inhibition of these enzymes resulted in unexpected physiological and pathological processes. Thus, it fueled the interest in matrix metalloproteinase and its inhibitors in medicinal and pharmaceutical chemists. This chapter discusses the therapeutic accomplishments of matrix metalloproteinase inhibitors in arthritis, autoimmune disease, inflammations, cancer, and cardiovascular disease. Further, the chapter discusses clinical trial implications, obstacles, and future research.
-
From This Site
/content/books/9789811460821.chapter-6dcterms_subject,pub_keyword-contentType:Journal105
